William Hoffman, Director at Inari Medical, Inc. (NARI), sold 80,000 shares at $45.57 ($3.6M) on 2024-10-16, disclosed to the SEC on 2024-10-18.
Scheduled sale ($3.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.78 | 27,804 | $1.2M | 34.6% |
| 2 | $44.78 | 27,804 | $1.2M | 34.6% |
| 3 | $45.57 | 12,196 | $556K | 15.4% |
| 4 | $45.57 | 12,196 | $556K | 15.4% |
| Total | $45.02 avg | 80,000 | $3.6M | 100% |
| Filing → |
| NARI | SELL | 2024-11-20 | $5.5M | — | Filing → |
| NARI | SELL | 2024-10-31 | $2.0M | — | Filing → |
| NARI | SELL | 2024-09-18 | $3.7M | — | Filing → |